NSE filing, NSE: INVICTA. Summary written from the filing by ALFA Finder's alert engine.
Invicta Diagnostic Ltd: key numbers
- Share price
- ₹66.00
- Market cap
- ₹82.98 Cr
- Revenue (annual)
- ₹32.35 Cr
- Net profit (annual)
- ₹4.91 Cr
- P/E (TTM)
- 16.9×Sector 53.7×
- Promoter holding
- 66.70%
- FII holding
- 1.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Invicta Diagnostic Ltd
All →Invicta Diagnostic Management Change
Invicta Diagnostic Limited reported changes to its leadership and audit team, including a director's re-appointment, a designation change, and a new secretarial auditor.
Invicta Diagnostic Annual General Meeting
Invicta Diagnostic Limited conducted its 3rd Annual General Meeting on September 19, 2026. The proceedings detailed company operations and future financial targets.
Invicta Diagnostic Board Meeting Outcome
Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.
Invicta Diagnostic Capacity Expansion
Invicta's subsidiaries commenced operations at two diagnostic centres in Shegaon and Pune. Investment is Rs. 70 lakhs for CT scan and pathology services.
- diagnostic service centres
- 2 centres
Invicta Diagnostic Annual General Meeting
Invicta Diagnostic approved the notice for its 3rd Annual General Meeting scheduled for 19th September 2026, alongside adoption of financial reports and director appointments.
Invicta Diagnostic Merger & Restructuring Worth ₹0.01 Cr
Invicta Diagnostic Limited is selling its associate entity, MSCRIBEIT INFOTECH LLP, for a cash consideration of Rs. 50,000. The transaction is expected to conclude by March 2027.
- Value
- ₹0.01 Cr
Other board meeting date announcements
All →Northern Spirits Board Meeting Date
Northern Spirits Limited issued a prior intimation that its Board meeting is scheduled for 12 Nov 2026 to consider unaudited Q2/H1 FY27 results. Trading window remains closed till 14 Nov 2026.
Pan Electronics India Board Meeting Date
PAN Electronics (India) intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 18 November 2026.
Mangalam Industrial Finance Board Meeting Date
Mangalam Industrial Finance scheduled a board meeting for November 6, 2026. It will consider unaudited Q2 and H1 FY27 standalone results.
Olympic Cards Board Meeting Date
Olympic Cards schedules a board meeting on 12 November 2026 to consider unaudited quarterly results. The trading window stays closed until results are declared.
Vaishali Pharma Board Meeting Date
Vaishali Pharma has scheduled an audit committee meeting for 5 November 2026. Proposed agenda includes a fund raise via preferential issue and an increase in authorised capital.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.